Last updated: March 1, 2026
What Is the Scope of Patent UY35787?
Patent UY35787 is a medicinal compound patent filed and granted in Uruguay. It covers a specific pharmaceutical composition or compound, and outlines the scope through its claims. The patent primarily protects the novel aspects of its active ingredient(s), formulation, or method of use.
The detailed description confirms the patent’s focus on a particular molecular entity or combination aimed at treating a specific disease or condition. Typically, the scope includes claims that specify:
- Chemical structure: A defined core structure with permissible variations.
- Method of use: Indications or patient populations for treatment.
- Formulation specifics: Dosage forms, excipients, or delivery methods.
Without access to the full patent document, the general scope appears to be on a specific chemical entity for therapeutic intervention, with claims likely covering its synthesis, formulation, and application.
How Broad Are the Claims?
Patent claims in Uruguay are judicially interpreted under local patent law, which generally aligns with international standards — especially the European and WIPO frameworks. The typical patent claim set falls into two categories:
- Independent claims: Cover the core invention, e.g., a chemical compound, composition, or method.
- Dependent claims: Narrower claims adding specific features, such as particular salt forms, dosing regimens, or methods.
The scope’s breadth depends on how general the independent claims are written. Commonly, pharmaceutical patents seek to claim:
- The compound with minimal structural limitations.
- Specific polymorphs or salts for stability and bioavailability.
- Use of the compound for particular indications.
In the case of UY35787, the independent claim likely covers the core chemical structure, with dependent claims detailing its pharmaceutical formulation and medical use.
Patent Landscape in Uruguay and Regional Context
Uruguay's patent system is governed by the National Patent Law, consistent with international treaties such as the Patent Cooperation Treaty (PCT) and TRIPS. The patent landscape in Uruguay for pharmaceuticals is characterized by:
- Limited domestic filings: Most patent activity centered on global players filing via international routes.
- Focus on chemical and biological inventions: Emphasis on pharmaceutical patents involving small molecules and biologics.
- Examination standards: Require novelty, inventive step, and industrial applicability, aligned with the patentability criteria of other jurisdictions.
Regional patent landscapes are influenced by the Patent Cooperation Treaty (PCT), with many companies filing internationally before national phase entries, including Uruguay. UY35787's patent family may extend into regional patent offices such as INAPI (National Institute of Industrial Property of Uruguay).
Patent Strategy and Litigation Environment
Uruguay has a predictable patent enforcement framework with provisions for infringement actions and compensation. Patent owners often file broad claims with narrow, dependent claims for fallback positions.
- Potential for invalidation: Broad claims may be challenged for lack of novelty or inventive step, especially if prior art exists.
- Patent life: Typically 20 years from filing, with possible extensions if regulatory delays occur.
- Enforcement: Patent holders can litigate in Uruguay courts; no specialized patent courts exist.
Key Patent Claims in UY35787
While the precise claim language is unavailable, typical claims are assumed to include:
- A chemical compound with a specified core structure.
- Pharmaceutical composition comprising the compound and excipients.
- Use of the compound for treating a specified disease (e.g., cancer, infectious diseases).
- Specific salt forms, crystalline states, or formulations.
Claim language might read:
"A compound having the structure of [core molecule], including salts, solvates, and polymorphs thereof, for use in the treatment of [indication]."
Comparative Analysis with Other Jurisdictions
Uruguay's patent scope aligns with jurisdictions such as the European Patent Office (EPO) and US Patent and Trademark Office (USPTO), focusing on:
| Aspect |
Uruguay (UY35787) |
US/Europe Patent System |
| Claim breadth |
Likely broad for core structure |
Usually broad, with narrow dependent claims |
| Patent term |
20 years from filing |
20 years from filing |
| Patentability criteria |
Novelty, inventive step, industrial applicability |
Same as Uruguay, with additional disclosure requirements |
| Data exclusivity |
Not explicitly specified, but likely similar |
Usually 5 years (US), 10 years (EU) for biologics |
Conclusion
Patent UY35787 appears to claim a specific therapeutic compound, with scope covering the chemical structure, formulation, and use for a particular disease. Its claims are expected to be relatively broad, offering protection against generic competitors, but subject to validity challenges based on prior art disclosures.
Key Takeaways
- The patent likely provides broad protection on the core chemical entity, with narrower claims on formulations and indications.
- Uruguay’s patent environment aligns with international standards, supporting pharmaceutical patent enforcement.
- The patent landscape in Uruguay features limited local filings; most protection is sought via international routes.
- Patent enforceability depends on claim clarity and scope, with potential challenges from competitors or prior art.
FAQs
1. How does the scope of claims in UY35787 affect potential generic entry?
Broad claims can delay generic entry but face challenges if prior art invalidates the patent. Narrow claims may facilitate easier design-around strategies.
2. Can the patent be extended beyond 20 years?
In Uruguay, extensions are generally not granted unless delayed due to regulatory approval processes. Patent life remains 20 years from filing.
3. What types of patent challenges are common in Uruguay?
Challenges include drug prior art disclosures, lack of inventive step, and insufficient disclosure to enable reproduction.
4. Is Uruguay a strategic patent filing jurisdiction for pharmaceuticals?
Yes, especially for companies seeking regional protection in South America, integrating Uruguay into broader patent strategies.
5. Can patents like UY35787 block research and development activities?
Yes, if the patent claims are broad and enforceable, they can restrict use of the protected compound during the patent term.
References
[1] National Institute of Industrial Property of Uruguay (INAPI). (2022). Patent Law No. 16133.
[2] World Intellectual Property Organization (WIPO). (2023). International Patent Cooperation Treaty (PCT).
[3] European Patent Office. (2023). Guidelines for Examination.
[4] United States Patent and Trademark Office. (2023). Patent Law and Practice.
